Abstract:Objective To observe the efficiency of ezetimibe/simvastatin (ES) tablets on the regression of atherosclerotic plaque of abdominal arteries in rabbits. Methods Twenty-four healthy male New Zealand rabbits were randomly divided into 2 groups: control group (n=8) and hypercholesterolemia group (n=16). Control group was fed with normal diet for 12 weeks. The other group animals were given a cholesterol-supplemented diet (normal diet+15g/L cholesterol+100g/L lard+150g/L egg yolk powder) for 2 weeks, and underwent catheter-induced arterial wall injury. These rabbits were then randomized to model subgroup (n=8, for another 10 weeks of hypercholesterol diet) and ES treatment subgroup [n=8, 5/10mg/(kg·d) for another 10 weeks]. Chinese russell’s viper venom was intra-peritoneally injected to trigger plaque rupture. Abdominal aortagraphy was carried out to measure the aorta stenosis. After 12 weeks’ feeding, all rabbits were sacrificed, and their abdominal arteries were isolated, paraffin-embedded and then sectioned. Blood lipid and lipoproteins were detected. The development of the atherosclerotic plaques was evaluated through the light microscopy. Finally, the expression of macrophage and smooth muscle actin in the abdominal arteries was measured by immunohistochemical analysis. Results The serum levels of total cholesterol (TC), triglycerides (TG) and low density lipoprotein-cholesterol (LDL-C) were significantly lower in the ES treatment subgroup than in the hypercholesterolemia model group (P<0.01). One-way analysis of variance indicated that significant differences were found in the plaque diameter, plaque thickness and the intimal-medial thickness between the ES subgroup and hypercholesterolemia model subgroup by morphological observation (P<0.05). Immunohistochemical analysis showed that lesser macrophages (P<0.05) but more smooth muscle cells (P<0.01) were found in the ES treatment subgroup than in the model group. Conclusion It may be through reducing the deposition of extracellular lipids that ES treatment decreases macrophage number and cholesterol level, increases the collagen and smooth muscle cells in the arterial intima and media, and thus exerts effect on plaque reversing.